Dosing Therapeutic Radiopharmaceuticals in Obese Patients

The prevalence of obesity has increased dramatically in the Western population. Obesity is known to influence not only the proportion of adipose tissue but also physiological processes that could alter drug pharmacokinetics. Yet, there are no specific dosing recommendations for radiopharmaceuticals...

Descripción completa

Detalles Bibliográficos
Autores principales: van Nuland, Merel, Ververs, Tessa F., Lam, Marnix G. E. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775906/
https://www.ncbi.nlm.nih.gov/pubmed/35055005
http://dx.doi.org/10.3390/ijms23020818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775906/
https://www.ncbi.nlm.nih.gov/pubmed/35055005
http://dx.doi.org/10.3390/ijms23020818

Ejemplares similares